A stronger Ozempic, Wegovy sales boom, and Hims’ generic weight loss drug: Pharma news roundup

The company is offering compounded semaglutide, the active ingredient in Ozempic and Wegovy, for $199 a month this year.

Image: Hims & Hers (Getty Images)

The millennial-skewed telehealth platform Hims & Hers (HIMS) announced this week that it will start offering customers a generic version of liraglutide, an older GLP-1 weight loss drug, next year. The news comes as some patients still struggle to fill prescriptions of the most advanced branded GLP-1 treatments on the market, like Zepbound, Wegovy, and Ozempic.

A stronger Ozempic, Wegovy sales boom, and Hims’ generic weight loss drug: Pharma news roundup

Similar Content